Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals

$4.40 0.06 (1.38%)

High $4.46	Low $4.23	Trades 1,020	Turnover $2,463,536	Volume 565,229
30 June 2023 at 4:10pm

Market Cap (31-Jul) $238,050,272 (439th)	Close (30-Jun) $4.40 0 (0%)	Volume (30-Jun) 565,229	Shortsold (28-Jul) 1,904,163 (2.34%) (140th)
52w High $6.50	52w Low $2.04	P/E 263.16	EPS -1.04

Short Interest

ASIC data, 28 Jul 2026

% Shorted

2.34% 0.02

vs 2.36% prior report

Most Shorted Rank

140th

of 710 shorted ASX stocks

Peak Short

13.53%

May 2017

Days to Cover

7.7

at 50d avg vol

View full short position history →

	Subject
	MYX MYX Ann: Initial Director's Interest Notice
	1 (current) 2 3
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Non-Executive Director appointment and retirement
	MYX MYX Ann: 2022 Full Year Investor Presentation
	MYX MYX Ann: 2022 Full Year Media Release
	MYX MYX Ann: Appendix 4E and Statutory Accounts
	MYX MYX Ann: Mayne Pharma CEO announces plan to retire
	MYX MYX Ann: Ceasing to be a substantial holder
	MYX MYX Ann: Mayne Pharma announces sale of Metrics Contract Services
	MYX MYX Ann: FDA approval of HALOETTE, a generic version of NUVARING
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: NEXTSTELLIS nominated for 2022 Prix Galien USA Award
	MYX MYX Ann: Update - Notification of buy-back - MYX
	MYX MYX Ann: MYX and GoodRx announce NEXTSTELLIS DTC campaign
	MYX MYX Ann: NEXTSTELLIS oral contraceptive now available in Australia
	MYX MYX Ann: Mayne Pharma appoints new CFO
	MYX MYX Ann: Notification of buy-back - MYX
	MYX MYX Ann: Change in substantial holding
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Wilsons investor conference presentation
	MYX MYX Ann: Notice under ASX Listing Rule 3.10A
	MYX MYX Ann: Mayne Pharma recipient of $4.8m Federal Government Grant
	MYX MYX Ann: Initial Director's Interest Notice
	MYX MYX Ann: Non Executive Director Appointment
	MYX MYX Ann: Final Director's Interest Notice
	MYX MYX Ann: 2022 Half Year Investor Presentation
	MYX MYX Ann: 2022 Half Year Media Release
	MYX MYX Ann: Half Yearly Report and Accounts
	MYX MYX Ann: Ceasing to be a substantial holder
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Mayne Pharma expands US dermatology portfolio
	MYX MYX Ann: Becoming a substantial holder
	MYX MYX Ann: Ceasing to be a substantial holder
	MYX MYX Ann: Initial Director's Interest Notice
	MYX MYX Ann: Non-Executive Director appointment and retirement
	MYX MYX Ann: Mayne Pharma adds a generic PROTOPIC to US portfolio
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Notification regarding unquoted securities - MYX
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: TGA approval of novel oral contraceptive NEXTSTELLIS
	MYX MYX Ann: Results of Meeting
	MYX MYX Ann: 2021 Mayne Pharma AGM Speeches
	MYX MYX Ann: 2021 AGM Notice of Meeting and Shareholder Pack
	MYX MYX Ann: 2021 Corporate Governance Statement and Appendix 4G
	MYX MYX Ann: Annual Report to shareholders
	MYX MYX Ann: MAYNE PHARMA provides FDA update on generic NUVARING
	MYX MYX Ann: Initial Director's Interest Notice
	MYX MYX Ann: Final Director's Interest Notice (x2)
	MYX MYX Ann: Mayne Pharma appoints new Director

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
31-Jul	$2.66	407,453	+0.06 (2.31%)
30-Jul	$2.60	223,169	-0.04 (1.52%)
29-Jul	$2.64	126,272	+0.02 (0.76%)
28-Jul	$2.62	92,042	-0.01 (0.38%)
27-Jul	$2.63	174,522	-0.08 (2.95%)
24-Jul	$2.71	143,096	-0.02 (0.73%)
23-Jul	$2.73	184,578	-0.04 (1.44%)
22-Jul	$2.77	174,805	+0.02 (0.73%)
21-Jul	$2.75	155,511	-0.06 (2.14%)
20-Jul	$2.81	71,066	-0.07 (2.43%)
17-Jul	$2.88	73,205	-2.10 (42.17%)
18-Sep	$4.98	255,238	+0.45 (9.93%)
12-Sep	$4.53	218,772	0.00 (0.00%)
11-Sep	$4.53	219,294	-0.75 (14.20%)
05-Sep	$5.28	170,367	+0.01 (0.19%)
5 up, 9 down, and 1 flat days

Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mayne Pharma Group Health Care Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals